NCT07406776

Brief Summary

Early miscarriage (EM) is defined as the spontaneous expulsion of an intrauterine pregnancy of less than 14 weeks' duration. Early miscarriage is a very common complication, affecting more than 10% of pregnancies. Because of its frequency, EM is often considered a trivial event, particularly by healthcare professionals. However, for the women who experience it, EM can be a traumatic event, difficult to discuss with their families, and a source of worries and questions for subsequent pregnancies. The international literature is consistent on the psychological morbidity associated with miscarriage: anxiety, depression and post-traumatic stress disorder have been studied in women following CPT. The identification of a history of EM by doctors is therefore important for the overall management of women's health. The 2021 National Perinatal Survey showed that less than 5% of pregnant women in France had their first six months of pregnancy monitored by a general practitioner, a proportion that has been steadily declining in recent years. The majority of women are monitored by a gynecologist, or in 40% of cases by a midwife. These professionals therefore appear to be the preferred point of contact for women in the event of a miscarriage. In the absence of specific information, either from the woman herself or from the healthcare professional who treated her, the general practitioner-the attending physician may remain unaware of this event in their patient's life. Under these circumstances, identifying a history of EM in the general practitioner's medical records may not be sufficient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
145

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 16, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 27, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 5, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 12, 2026

Completed
Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

February 5, 2026

Last Update Submit

February 12, 2026

Conditions

Keywords

early miscarriagetermination pregnancygeneral medical

Outcome Measures

Primary Outcomes (1)

  • notification of early miscarriage in the medical file of the woman who reported it.

    the frequency of notification of a history of early miscarriage in the attending physician's medical records.

    Day 0

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women aged between 18 and 50, who declared a GP participating in the study as their GP and agreed to take part in the study.

You may qualify if:

  • Female
  • Aged between 18 and 50
  • Whose GP has agreed to take part in the study
  • Agreeing to take part in the study.

You may not qualify if:

  • Minors
  • Over the age of 50
  • Protected by law (guardianship, curatorship, safeguard of justice)
  • Refusing to take part in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gestonnairedu CURRS

Reims, Champagne-Ardenne, 51100, France

Location

MeSH Terms

Conditions

Abortion, Spontaneous

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2026

First Posted

February 12, 2026

Study Start

May 16, 2025

Primary Completion

November 27, 2025

Study Completion

February 5, 2026

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations